Gain perspectives from experts on various policy issues and therapeutic areas through our Insights series that engages multiple managed care stakeholders in video interviews.

The Future of Axial Spondyloarthritis Treatment
May 31, 2019 – 
Hillary Norton, MD, discusses the unmet needs in the treatment of axial spondyloarthritis and provides community rheumatologists with management advice.
AxSpa Treatments: TNF Inhibitors, NSAIDs, and Opioids
May 31, 2019 – 
Hillary Norton, MD, enumerates the treatment options for axial spondyloarthritis, including nonpharmacologic methods, opioids, NSAIDs, and TNF inhibitors.
AxSpa Treatment Goals and Windows of Opportunity
March 28, 2019 – 
Hillary Norton, MD, considers the windows of opportunity in managing axial spondyloarthritis to prevent various comorbidities and discusses the goals of therapy.
 
Diagnosing Axial Spondyloarthritis
March 28, 2019 – 
Hillary Norton, MD, discusses the diagnosis of axial spondyloarthritis, namely the difficulties of accurate and timely identification, and considers possible comorbidities.
 
Advice for NrAxSpa Patients & Future of Treatment
March 21, 2019 – 
Tiffany Westrich-Robertson provides advice for people with nonradiographical axial spondyloarthritis, and considers the future of autoimmune and autoinflammatory treatment.

 
The Epidemiology of Axial Spondyloarthritis
March 21, 2019 – 
Hillary Norton, MD, discusses the epidemiology of axial spondyloarthritis.
Nonradiographic Versus Radiographic Axial Spondyloarthritis
March 21, 2019 – 
Hillary Norton, MD, considers the differences between nonradiographic and radiographic axial spondyloarthritis and discusses the impact of these diseases on everyday life.
The IFAA: Raising Awareness of NrAxSpa & Related Diseases
March 14, 2019 – 
Tiffany Westrich-Robertson provides an overview of the International Foundation for Autoimmune & Autoinflammatory Arthritis and discusses how it has affected patients with nonradiographical axial spondyloarthritis and related diseases.
Living With NrAxSpa Posttreatment
March 14, 2019 – 
Tiffany Westrich-Robertson discusses how certolizumab pegol has affected her day-to-day life.
 
The Impact of Certolizumab Pegol in Treating Nr-AxSpA
March 07, 2019 – 
Tiffany Westrich-Robertson considers how the process of identifying non-radiographical axial spondyloarthritis has changed over the years and emphasizes the importance of raising awareness of autoimmune and autoinflammatory diseases.
 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.